Sasha Shulgin Godfather Of Ecstasy Dead Business Insider

Over 70% New & Buy It Now; This Is The New ebay. Find Shulgin Alexander now! Alexander Theodore " Sasha " Shulgin (June 17, 1925 - June 2, 2014) was an American medicinal chemist, biochemist, organic chemist, pharmacologist, psychopharmacologist, and author.

Alexander ( Sasha ) Shulgin Alexander shulgin, Spiritual art, Chemistry

Mike Power @mrmichaelpower Tue 3 Jun 2014 08.58 EDT Alexander "Sasha" Shulgin, who has died aged 88, was a pioneering and fearless scientist, but his chosen discipline - the design and synthesis. Alexander "Sasha" Shulgin, I learned later, was a top-rank researcher for Dow Chemical in 1960 when he ingested a psychedelic compound—mescaline—for the first time. Shulgin found the experience. Alexander T. Shulgin (June 17, 1925-June 2, 2014), known to friends and admirers as "Sasha", was a biochemist and pharmacologist best known for his synthesis, creation, and personal bioassay of hundreds of novel psychoactive compounds. Sasha was born in Berkeley, California. He first began his study of organic chemistry at Harvard University. About Sasha. Alexander T. ("Sasha") Shulgin was a visionary chemist credited with creating over 150 new psychedelic compounds and with identifying the unique psychological properties of MDMA, well-known as the prototype for a class of drugs named "empathogens" (sometimes called "entactogens") for their abilities to generate feelings of empathy, compassion, and enhanced.

Alexander Shulgin, Psychedelia Researcher, Dies at 88 The New York Times

Ann Shulgin, who alongside her husband, Alexander Shulgin, developed and experimented with hundreds of psychedelic drugs that he concocted in his California laboratory, then showed readers. Alexander Theodore Shulgin, who was known as Sasha to friends, was born in Berkeley, Calif., on June 17, 1925. His parents were teachers, and he was a precocious student, entering Harvard at 16. Alexander Shulgin, the researcher who transformed MDMA from an obscure chemical to a party drug known as Ecstasy, has died at his home in Northern California. He was 88, and the cause was liver. Alexander "Sasha" Shulgin, a chemist and psychopharmacologist who introduced the world to the drug MDMA — later called Ecstasy — while creating hundreds of other psychedelic drugs that ultimately.

Alexander “Sasha” Shulgin A Retrospective Truffle Report

Alexander "Sasha" Shulgin, the pioneering pharmacologist who introduced MDMA to psychologists in the 1970s, has died aged 88 after a battle with liver cancer. Alexander "Sasha" Shulgin, the chemist and pharmacologist known for creating hundreds of psychoactive drugs and popularising MDMA, has died at his home aged 88. Shulgin, known as the Godfather of Ecstasy, died from liver cancer, having already been suffering a spate of ill health down the years, including a stroke and the early stages of dementia. Tue 3 Jun 2014 11.55 EDT. It's quite a trip to visit maverick pharmacologist Dr Alexander Shulgin and his collaborator and wife, Ann, at their rustic home in California. It is a warm secluded. When chemist Alexander "Sasha" Shulgin died Monday night at the age of 88, his legacy was quickly summed up in three words: "Godfather of Ecstasy.". It's the easiest characterization of the chemist because his '70s-era synthesis of the Ecstasy (3,4-methylenedioxymethamphetamine or MDMA) is the most well known of his work.

Alexander Shulgin, 'Godfather of Ecstasy', Dies At 88

Alexander (Sasha) Shulgin, the brilliant miscreant chemist who discovered scores of psychedelic drugs — including MDMA (or "Ecstasy," which he called a "low-calorie martini" — was dubbed one of the century's most important scientists by Timothy Leary. Working from a lab behind his Lafayette home on "the Farm," he and his wife Ann, with occasional… news. Dr. Alexander Shulgin, the influential and beloved psychedelic pioneer, has passed away at the age of 88. He died of liver cancer on Monday, 2 June, surrounded by family and friends at his home in California. Shulgin had suffered declining health in the past few years, including a stroke and the onset of dementia beginning in 2010.